SEATTLE – Jan. 6, 2014 – After a hugely successful and fun inaugural Obliteride 2013, Fred Hutchinson Cancer Research Center is gearing up for the second annual community fundraising bike ride to raise money to help end cancer. Rider registration for the Aug. 8-10, 2014 event opens today at Obliteride.org. Register early to hold your spot in Obliteride 2014.
“Community support for Obliteride has been outstanding,” said Amy Lavin, Obliteride’s executive director. “In 2014 we’re looking for that support to result in even more riders and higher fundraising. That means we accelerate cancer research and discovery, and save lives faster. Having fun together is also a part of it!”
Exciting Changes for 2014
Participants can expect an even better Obliteride experience in 2014, including:
- New routes and days: The 25-, 50- and 100-mile rides start and finish at Seattle’s Magnuson Park on Sunday, Aug. 10. Riders head south this year and enjoy fantastic scenery along Lake Washington Boulevard, Seward Park, Mercer Island, May Valley, Tiger Mountain and Lake Sammamish, depending on the route. The 150-mile ride starts on Saturday, Aug. 9, at the Seattle Ferry Terminal and includes beautiful Puget Sound vistas and challenging terrain on Bainbridge Island and the Kitsap Peninsula with an overnight at UPS in Tacoma. The 150-mile ride ends on Sunday, Aug. 10, at a finish line festival at Magnuson Park where all riders, their families and volunteers will celebrate together with fantastic food and live music. All riders are invited to the kick-off party at Gas Works Park on Friday, Aug. 8. More information at www.obliteride.org/ride.
- New ways to participate: This year, participants can choose relay and point-to-point ride options for the 150-mile route. They can ride the 85 miles from Seattle to UPS in Tacoma on Saturday, or the 65-mile return from UPS to Seattle on Sunday. Or get a buddy to split the riding days and form a relay team. Details at www.obliteride.org/ride.
Because of the support of Obliteride’s generous underwriters, like University Village, 100% of every dollar raised goes directly to cancer research, making Obliteride a unique and powerful way to support the fight against cancer.
In 2013, Obliteride raised nearly $2 million for lifesaving cancer research at Fred Hutch, setting a fundraising record for raising more money for a local organization than any other bicycling fundraiser in the Northwest. With the community’s help, Obliteride organizers expect to shatter the fundraising record set in 2013.
Obliteride is a community that cares fiercely about ending cancer. We connect over the impact cancer is having on our lives and our intense commitment to find better treatments and ultimately eliminate it. We believe that together we can make a difference. Together we can end cancer. Join the movement to obliterate cancer. It’s fun, focused and full of energy! 100% of every dollar raised goes directly to lifesaving cancer research at Fred Hutch. Obliteride 2014 is Aug. 8-10. Learn more at www.obliteride.org.
# # #
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit www.fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.
Obliteride Media Relations
Fred Hutchinson Cancer Research Center